Development of integrase inhibitors for treatment of AIDS: An overview

European Journal of Medicinal Chemistry

Volumn 42, Issue 9, 2007, Pages 1159-1168

  Dubey, Sonal ^a   Satyanarayana, Y D ^a   Lavania, Harshita ^a  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

Author keywords

AIDS; Catechol; Diketoacids; HIV 1; Integrase inhibitors; Non catechol; Quinoline

Indexed keywords

1 [5 (4 FLUOROBENZYL) 2 FURYL] 3 (1,2,4 TRIAZOL 3 YL) 1,3 PROPANEDIONE; 4 [1 (4 FLUOROBENZYL) 2 PYRROLYL] 2,4 DIOXOBUTYRIC ACID; 5 HYDROXY 1 METHYL 2 [1 METHYL 1 [(5 METHYL[1,3,4]OXADIAZOLE 2 CARBONYL)AMINO]ETHYL] 6 OXO 1,6 DIHYDROPYRIMIDINE 4 CARBOXYLIC ACID 4 FLUOROBENZYLAMIDE; 6 AMINO 1,4 DIHYDRO 1 METHYL 7 [4 (2 PYRIDYL) 1 PIPERAZINYL] 4 OXO 3 QUINOLINECARBOXYLIC ACID; 6 OXOCYTIDINE; CAFFEIC ACID PHENETHYL ESTER; CARBOXYLIC ACID DERIVATIVE; CATECHOL DERIVATIVE; COSALANE; COUMARIN DERIVATIVE; CURCUMIN; FLAVONE DERIVATIVE; FLAVONOID; GRANULATINE; GS 9137; HYDRAZIDE DERIVATIVE; INTEGRASE INHIBITOR; INTEGRIC ACID; JTK 303; L 708906; L 870812; LIGNAN DERIVATIVE; MK 0518; N (4 FLUOROBENZYL) 8 HYDROXY 5 (TETRAHYDRO 2H 1,2 THIAZIN 2 YL) 1,6 NAPHTHYRIDINE 7 CARBOXAMIDE S,S DIOXIDE; NAPHTHYRIDINE DERIVATIVE; QUINIC ACID; QUINOLINE DERIVATIVE; SALICYLHYDRAZIDE; SULFONAMIDE; SULFONE DERIVATIVE; TYRPHOSTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; SHORT SURVEY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELLS, CULTURED; HIV INTEGRASE INHIBITORS; HUMANS; VIRUS REPLICATION;

EID: 34547850200     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.01.024     Document Type: Short Survey

References (92)

1. Barre-Sinoussi F., Chermann J.C., Nugeyre M.T., Chamaret S., Gruest J., Dauget C., Axler-Bin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., and Montagnier L. Science 220 (1983) 868-871
2. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kalpana M., Haynes B.F., Palker T.J., Redfield R., Oleske J., Safai B., White G., Foster P., and Markham P.D. Science 224 (1984) 500-503
3. Fauci A., Macher A., Longo D., Lane H.C., Rook A., Masur H., and Gelmann E. Ann. Intern. Med. 100 (1984) 92-106
4. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. J. Med. Chem. 338 (1998) 853-860
5. Mehanna A.S. In: Burger A., Abraham D.J., Andrako J., Block J.H., Borchardt R.T., and Abraham A. (Eds). Rationale of Design of Anti-HIV Drugs. sixth ed. Burger's Medicinal Chemistry and Drug Discovery vol. 5 (2003), John Wiley and Sons, Inc., New Jersey 4574-4584
6. Pedersen O.S., and Pedersen E.B. Antivir. Chem. Chemother. 10 (1999) 285-314
7. De Clercq E. J. Med. Chem. 38 (1995) 2491-2517
8. Vacca J.P., and Condra J.H. Drug Discov. Today 2 (1997) 261-267
9. Hirsch M.S., Conway B., D'Aquila R.T., Johanson V.A., Brun-Vezinet F., Clotet B., Demeter L.M., Hammer S.M., Jacobsen D.M., Kuritzkes D.R., Loveday C., Mellors J.W., Vella S., and Richman D.D. JAMA 279 (1998) 1984-1991
10. Parolin C., Gatto B., Vecchio C.D., Pecere T., Tramontano E., Cecchetti V., Fravolini A., Masiero S., Palumbo M., and Palu G. Antimicrob. Agents Chemother. 47 (2003) 889-896
11. LaFemina R.L., Schneider C.L., Robbins H.L., Callahan P.L., LeGrow K., Roth E., Schleif W.A., and Emini E.A. J. Virol. 66 (1992) 7414-7419
12. Debyser Z., Cherepanov P., Maele B.V., De Clercq E., and Witvrouw M. Antivir. Chem. Chemother. 13 (2002) 1-15
13. Bushman F.D., and Craige R. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1339-1343
14. Sechi M., Derudas M., Dallocchio R., Dessi A., Bacchi A., Sannia L., Carta F., Palomba M., Ragab O., Chan C., Shoemaker R., Sei S., Dayam R., and Neamati N. J. Med. Chem. 47 (2004) 5298-5310
15. Asante-Appiah E., and Skalka A.M. Adv. Virus Res. 52 (1999) 351-369
16. Sakai H., Kawamura M., Sakuragi J., Sakurgi S., Shibata R., Ishimoto A., Ono N., Ueda S., and Adachi A. J. Virol. 7 (1993) 1169-1174
17. Taddeo B., Haseltine W.A., and Farnet C.M. J. Virol. 68 (1994) 8401-8405
18. Engleman A., Englund G., Orenstein J.M., Martin M.A., and Craige R. J. Virol. 69 (1995) 2729-2736
19. Kulkosky J., Jones K.S., Katz R.A., Mack J.P., and Skalka A.M. Mol. Cell. Biol. 12 (1992) 2331-2338
20. Khan E., Mack J.P., Katz R.A., Kulkosky J., and Skalka A.M. Nucleic Acids Res. 19 (1991) 851-860
21. Cannon P.M., Byles E.D., Kingsman S.M., and Kingsman A.J. J. Virol. 70 (1996) 651-657
22. Craigie R. J. Biol. Chem. 276 (2001) 23213-23216
23. Johanson A.A., Marchand C., and Pommier Y. Curr. Top. Med. Chem. 4 (2004) 671-686
24. Neamati N. Expert Opin. Ther. Pat. 12 (2002) 709-724
25. Cushman M., and Sherman P. Biochem. Biophys. Res. Commun. 185 (1992) 85-90
26. Lafemina R.L., Graham P.L., Legrow K., Hastings J.C., Wolfe A., Youg S.D., Emini E.A., and Hazuda D.J. Antimicrob. Agents Chemother. 39 (1995) 320-324
27. Mazumder A., Wang S., Neamati N., Nicklaus M., Sunder S., Chen J., Milne G., Rice W.G., Burke T.R., and Pommier Y. J. Med. Chem. 39 (1996) 2472-2481
28. Fesen M.R., Pommier Y., Leteurtre F., Hirogouchi S., Yung J., and Kohn K.W. Biochem. Pharmacol. 48 (1994) 595-608
29. Mazumder A., Raghavan K., Weinstein J., Kohn K.W., and Pommier Y. Biochem. Pharmacol. 49 (1995) 1165-1170
30. Mazumder A., Neamati N., Sunder S., Schulz J., Pertz H., Eich E., and Pommier Y. J. Med. Chem. 40 (1997) 3057-3063
31. Mazumder A., Gazit A., Levitzki A., Nicklaus M., Yung J., Kohlhagen G., and Pommier Y. Biochemistry 34 (1995) 15111-15122
32. Eich E., Pertz H., Kaloga M., Schulz J., Fesen M.R., Mazumder A., and Pommier Y. J. Med. Chem. 39 (1996) 86-95
33. Zhao H., Neamati N., Hong H., Mazumder A., Wang S., Sunder S., Milne G.W.A., Pommier Y., and Burke Jr. T.R. J. Med. Chem. 40 (1997) 242-249
34. Cushman M., Golebiewsky W.M., Pommier Y., Mazumder A., Reymen D., De Clercq E., Graham L., and Rice W.G. J. Med. Chem. 38 (1995) 443-452
35. Zhao H., Neamati N., Sunder S., Hong H., Wang S., Milne G.W.A., Pommier Y., and Burke Jr. T.R. J. Med. Chem. 40 (1997) 937-941
36. Neamati N., Hong H., Mazumder A., Wang S., Sunder S., Nicklaus M.C., Milne G.W.A., and Pommier Y. J. Med. Chem. 40 (1997) 942-951
37. Melouar K., Mouscadet J., Desmaele D., Subra F., Leh H., Savoure D., Auclair C., and D'Angelo J. J. Med. Chem. 41 (1998) 2846-2857
38. Reddy M.V.R., Rao M.R., Rhodes D., Hansen M., Rubins K., Bushman F.D., Venkateshwarlu Y., and Faulkner D.J. J. Med. Chem. 42 (1999) 1901-1907
39. Robinson W.E., Reinecke M.G., Abdel M.S., Jia Q., and Chow S.A. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6326-6331
40. Neamati N., Hong H.X., Sunder S., Milne G.W.A., and Pommier Y. Mol. Pharmacol. 52 (1997) 1041-1055
41. Neamati N., Hong H.X., Mazumder A., Wang S., Sunder S., Nicklaus M.C., Milne G.W.A., Proksa B., and Pommier Y. J. Med. Chem. 40 (1997) 942-951
42. King P.J., and Robinson Jr. W.E. J. Virol. 72 (1998) 8420-8424
43. Robinsonm Jr. W.E., Coideiro M., Abdel-Malek S., Jia Q., Chow S.A., Reinecke M.G., and Mitchell W.M. Mol. Pharmacol. 50 (1996) 846-855
44. McDougall B., King P.J., Wu B.W., Hostomsky Z., Reinecke M.G., and Robinson Jr. W.E. Antimicrob. Agents Chemother. 42 (1998) 140-146
45. Pluymers W., Neamati N., Pannecouque C., Fikkert V., Marchand C., Burke Jr. T.R., Pommier Y., Schols D., De Clercq E., Debyser Z., and Witvrouw M. Mol. Pharmacol. 58 (2000) 641-648
46. De Clercq E. Biochim. Biophys. Acta 1587 (2002) 258-275
47. Lin Z., Neamati N., Zhao H., Kiryu Y., Turpin J.A., Aberham C., Strebel K., Kohn K., Witvrouw M., Pannecouque C., Debsyer Z., De Clercq E., Rice W.G., Pommier Y., and Burke Jr. T.R. J. Med. Chem. 42 (1999) 1401-1414
48. Farnet C., Lipford R., Wang B., and Bushman F.D. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9742-9747
49. Higuchi H., Mori K., Kato A., Ohkuma T., Kaji H., and Kaji A. Antiviral Res. 15 (1991) 205-216
50. Schinazi R.F., Chu C.K., Babu J.R., Oswald B.J., Saalmann V., Cannon D.L., Errikson B.F.H., and Nasr M. Antiviral Res. 13 (1990) 265-272
51. Stanwell C., Ye B., Yuspa S.H., and Burke T.R. Biochem. Pharmacol. 52 (1996) 475-480
52. Burke Jr. T.R., Fesen M.R., Mazumdar A., Wang J., Carothers A.M., Grumberger D., Driscoll J., Kohn K., and Pommier Y. J. Med. Chem. 38 (1995) 4171-4178
53. Farnet C.M., Wang B., Hansen M., Lipford J.R., Zalkow L., Robinson Jr. W.E., Siegel J.S., and Bushman F.D. Antimicrob. Agents Chemother. 42 (1998) 2245-2253
54. Molteni V., Rhodes D., Rubins K., Hansen M., Bushman F.D., and Siegel J.S. J. Med. Chem. 43 (2000) 2031-2039
55. Sechi M., Angotzi G., Dallocchio R., Dessi A., Carta F., Sannia L., Mariani A., Fiori S., Sanchez T., Movsessian L., Plasencia C., and Neamati N. Antivir. Chem. Chemother. 15 (2004) 67-81
56. Goldgur Y., Craigie R., Cohen G.H., Fugiwara T., Yoshinaga T., and Fujishita T. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13040-13043
57. Hazuda D.J., Felock P.J., Witmer M., Wolfe K., Stillmock J.A., Espeseth A., Gabryelski L., Scheif W., Blau C., and Miller M.D. Science 287 (2000) 646-650
58. Debyser Z., Cherepanov P., Pluymers W., and De Clercq E. Nucleases. In: Schein C.H. (Ed). Methods in molecular biology (2001), Human Press, Totowa, N.J. 139-155
59. Pluymers W., Pais G., Maele B.V., Pannecouque C., Fikkert V., Burke Jr. T.R., De Clarke E., Witvrouw M., Neamati N., and Debyser Z. Antimicrob. Agents Chemother. 46 (2002) 3292-3297
60. Maurin C., Bailly F., Buisine E., Vezin H., Mbemba G., Mouscadet J.F., and Cotelle P. J. Med. Chem. 47 (2004) 5583-5586
61. Wai J.S., Egberston M.S., Payne L.S., Fisher M.W., Tran L.O., Melamed J.Y., Langford H.M., Guare Jr. J.P., Zhuang L., Grey V.E., Vacca J.P., Holloway M.K., Naylor-Olsen A.M., Hazuda D.J., Felock P.J., Wolfe A.L., Gabryelski L.J., and Young S.D. J. Med. Chem. 43 (2000) 4923-4926
62. T. Kawasuji, T. Yoshinaga. Patent WO 01 17,968.
63. Chem. Abstr. 134 (2001) 2347486m
64. Costi R., Santo R.D., Artico M., Roux A., Ragno R., Massa S., Tramontano E., La Colla M., Loddo R., Marongiu M.E., Pani A., and La Colla P. Bioorg. Med. Chem. Lett. 14 (2004) 1745-1749
65. Svarovskaia E.S., Barr R., Zhang X., Pais G.C., Marchand C., Pommier Y., Burke Jr. T.R., and Pathak V.K. J. Virol. 78 (2004) 3210-3222
66. Billich A. Curr. Opin. Investig. Drugs 4 (2003) 206-209
67. Maurin C., Bailly F., Mbemba G., Mouscadet J.F., and Cotelle P. Bioorg. Med. Chem. 14 (2006) 2978-2984
68. Sechi M., Sannia L., Carta F., Palomba M., Dallocchio R., Dessi A., Derudas M., Zawahir Z., and Neamati N. Antivir. Chem. Chemother. 16 (2005) 41-61
69. Makhija M.T., Kasliwal R.T., Kulkarni V.M., and Neamati N. Bioorg. Med. Chem. 12 (2004) 2317-2333
70. Neamati N., Hong H., Sunder S., Milne G.W., and Pommier Y. Mol. Pharmacol. 52 (1997) 1041-1055
71. Neamati N., Hong H., Owen J.M., Sunder S., Winslow H.E., Christensen J.L., Zhao H., Burke Jr. T.R., Milne G.W., and Pommier Y. J. Med. Chem. 41 (1998) 3202-3209
72. Zhao H., Neamati N., Sunder S., Hong H., Wang S., Milne G.W., Pommier Y., and Burke Jr. T.R. J. Med. Chem. 40 (1997) 937-941
73. Hazuda D., Blau C.U., Felock P., Hasting J., Pramanik B., Wolfe A., Bushman F., Farnet C., Goetz M., Williams M., Silverman K., Lingham R., and Singh S. Antivir. Chem. Chemother. 10 (1999) 63-70
74. Fournet A., Vagneur B., Richomme P., and Bruneton J. Can. J. Chem. 67 (1989) 2116-2118
75. Fakhfakh M.A., Franck X., Fournet A., Hocquemiller R., and Figadere B. Tetrahedron Lett. 42 (2001) 3847-3850
76. Fakhfakh M.A., Franck X., Hocquemiller R., and Figadere B. J. Organomet. Chem. 624 (2001) 131-135
77. Franck X., Fournet A., Prina E., Mahieux R., Hocquemiller R., and Figadere B. Bioorg. Med. Chem. Lett. 14 (2004) 3635-3638
78. Benard C., Zouhiri F., Normand-Bayle D.M., Desmaele D., Leh H., Mouscadet J.F., Mbemba G., Thomas C.M., Bonnenfant S., Le Bret M., and D'Angelo J. Bioorg. Med. Chem. Lett. 14 (2004) 2473-2476
79. Mekour K., Mouscadet J.F., Desmaele D., Subra F., Leh H., Savoure D., Auclair C., and d'Angelo J. J. Med. Chem. 41 (1998) 2846-2857
80. Ouali M., Laboulais C., Leh H., Gill D., Desmaele D., Mekouar K.J., Zouhiri F., d'Angelo J., Auclair C., Mouscadet J.-F., and Le Bret M. J. Med. Chem. 43 (2000) 1949-1957
81. Zouhiri F., Mouscadet J.F., Mekour K., Desmaele D., Savoure D., and Leh H. J. Med. Chem. 43 (2000) 1533-1540
82. Parolin C., Barbara G., Vecchio C.D., Pecere T., Tramontano E., Cecchetti V., Fravolini A., Masiero S., Palumbo M., and Palu G. Antimicrob. Agents Chemother. 47 (2003) 889-896
83. Cecchetti V., Parolin C., Moro S., Pecere T., Filipponi E., Calistri A., Tabarrini O., Gatto B., Palumbo M., Fravolini A., and Palu G. J. Med. Chem. 43 (2000) 3799-3802
84. Sato M., Motomura T., Aramaki H., Matsuda T., Yamshita M., Ito Y., Kawakami H., Matsuzaki Y., Watanabe W., Yamataka K., Ikeda S., Kodama E., Matsuoka M., and Shinkai H. J. Med. Chem. 49 (2006) 1506-1508
85. Pomarnacka E., and Kornicka A. Farmaco 56 (2001) 571-577
86. Neamati N., Turpin J.A., Winslow H.E., Christensen J.L., Williamson K., Orr A., Rice W.A., Pommier Y., Garofalo A., Brizzi A., and Campiani G. J. Med. Chem. 42 (1999) 3334-3341
87. Zhuang L., Wai J.S., Embrey M.W., Fisher T.E., Egberston N.S., Payne L.S., Guare Jr. J.P., Vacca J.P., Hazuda D.J., Felock P.J., Wolfe A.L., Stillmock K.A., Witmer M.V., Moyer G., Schleif W.A., Gabryelski L.J., Leonard Y.M., Lynch Jr. J.J., Michelson S.R., and Young S.D. J. Med. Chem. 46 (2003) 453-456
88. Guare J., Pai J.S., Gomez R.P., Anthony N.J., Jolly S.M., Cortes A.R., Vacca J.P., Felock P.J., Stillmock K.A., Schleif W.A., Moyer G., Gabryelski L.J., Jin L., Chen I.W., Hazuda D.J., and Young S.D. Bioorg. Med. Chem. Lett. 16 (2006) 2900-2904
89. http://aidsinfo.nih.gov/DrugsNew
90. Markowitz M., Morales-Ramirez J.O., Nguyen B.Y., Kovacs C.M., Steigbigel R.T., Cooper D.A., Liporace R., Schwartz R., Isaacs R., Gilde L.R., Wenning L., Zhao J., and Teppler H. J. Acquir. Immune Defic. Syndr. 43 (2006) 509-515
91. Middleton T., Lim H.B., Montgomery D., Rockway T., Tang H., Cheng X., Lu L., Mo H., Kohlbrenner W.E., Molla A., and Kati W.M. Antiviral Res. 64 (2004) 35-45
92. Brodin P., Pinskaya M., Parsch U., Bischerour J., Leh H., Romanova E., Engels J.W., Gottikh M., and Mouscadet J.F. Nucleosides, Nucleotides, Nucleic Acids 20 (2001) 481-486